
Clinical research won’t move faster until access improves
Jon Robson, CEO of Mamedica, explains why improving patient access is essential to faster, more inclusive and effective clinical research across the UK.

Jon Robson, CEO of Mamedica, explains why improving patient access is essential to faster, more inclusive and effective clinical research across the UK.

Gilead Science’s PrEP Hub® platform is a gamechanger in the fight against HIV – both the disease and the stigma.

How Danish engineering giant Danfoss is using advanced IoT and AI to deliver dramatic energy efficiency gains to buildings around the world.

The story behind Two Sigma’s Data Clinic’s mission to amplify data equity

Dr Sina Habibi, CEO of Cognetivity on a potentially groundbreaking screening solution which could revolutionise detecting early signs of Alzheimer’s and dementia

Creative storytelling transforms scientific breakthroughs into cultural movements — from mammoth meatballs to AI art — making innovation relatable, emotional, and impactful for the public

Patrick Samy, CEO of Span, says now is the time for tech companies to invest in employees’ mental health

Mary Jesse is CEO of MTI. In this podcast, Mary discusses the company’s diversity initiatives, how she broke down barriers early in her career, and why diversity is good business.

Alex Rahin is the Chief Product and Technology Officer at Cervest, a startup that uses AI to help businesses protect their assets from the risks and effects of climate change. He discusses the climate emergency knowledge gap and Cervest’s ambitious goals.

Jon Robson, CEO of Mamedica, explains why improving patient access is essential to faster, more inclusive and effective clinical research across the UK.